Thomas Malfait
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Thomas Malfait has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra Kautzky-Willer
Division of Endocrinology and Metabolism, Department of Medicine III Medical University of Vienna Vienna Austria
2 shared publications - Annelien Morlion
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium
2 shared publications Christa Nöhammer
Austrian Institute of Technology, Center for Health and Bioresources, Molecular Diagnostics, Vienna, Austria
2 shared publications- Dimitri Hemelsoet
Department of Neurology, Ghent University Hospital, Ghent, Belgium
2 shared publications - Eva Hulstaert
Department of Dermatology, Ghent University Hospital, Ghent, Belgium
2 shared publications Eveline Vanden Eynde
Center for Medical Genetics, Department of Biomolecular Medicine, Ghent University, C. Heymanslaan 10, 9000 Ghent, Belgium; OncoRNALab, Cancer Research Institute Ghent (CRIG), Ghent University, C. Heymanslaan 10, 9000 Ghent, Belgium
2 shared publications
Latest Publications
- Open Access
- 7 March 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (2)
Pneumothorax as a complication of dry needling technique
Dry needling involves the insertion of a solid needle into palpably taut muscle bands or muscle knots known as “myofascial trigger points”. After insertion, the needle may be redirected in several planes or electrically stimulated to cause muscle contraction, which has been proposed to relieve pain and improve range of motion. The technique is referred to as “dry” because no medication is injected. The underlying mechanism of action is subject to debate, as is the exact pathogenesis of myofascial trigger points [1]. Dry needling is used in the treatment of a variety of musculoskeletal disorders, such as tendinopathy, shoulder impingement, nonradicular neck pain and chronic lower back pain. Being considered as its Western counterpart, dry needling is similar to acupuncture, which originates from traditional Chinese medicine. The latter technique, however, focuses on “flows of life force” (chi) and aims to treat conditions in multiple organ systems, whereas the former is used mainly in the musculoskeletal field.
- 7 March 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (2)
Open AccessPneumothorax as a complication of dry needling technique
Dry needling involves the insertion of a solid needle into palpably taut muscle bands or muscle knots known as “myofascial trigger points”. After insertion, the needle may be redirected in several planes or electrically stimulated to cause muscle contraction, which has been proposed to relieve pain and improve range of motion. The technique is referred to as “dry” because no medication is injected. The underlying mechanism of action is subject to debate, as is the exact pathogenesis of myofascial trigger points [1]. Dry needling is used in the treatment of a variety of musculoskeletal disorders, such as tendinopathy, shoulder impingement, nonradicular neck pain and chronic lower back pain. Being considered as its Western counterpart, dry needling is similar to acupuncture, which originates from traditional Chinese medicine. The latter technique, however, focuses on “flows of life force” (chi) and aims to treat conditions in multiple organ systems, whereas the former is used mainly in the musculoskeletal field.
- Open Access
- 1 December 2020
- Published by Elsevier in Cell Reports
- Vol. 33 (13) , 108552
Charting Extracellular Transcriptomes in The Human Biofluid RNA Atlas
- 1 December 2020
- Published by Elsevier in Cell Reports
- Vol. 33 (13) , 108552
Open AccessCharting Extracellular Transcriptomes in The Human Biofluid RNA Atlas
- Open Access
- 5 November 2019
- Published by Cold Spring Harbor Laboratory in bioRxiv
- p. 823369
Charting extracellular transcriptomes in The Human Biofluid RNA Atlas
Extracellular RNAs present in biofluids have emerged as potential biomarkers for disease. Where most studies focus on plasma or serum, other biofluids may contain more informative RNA molecules, depending on the type of disease. Here, we present an unprecedented atlas of messenger, circular and small RNA transcriptomes of a comprehensive collection of 20 different human biofluids. By means of synthetic spike-in controls, we compared RNA content across biofluids, revealing a more than 10 000-fold difference in RNA concentration. The circular RNA fraction is increased in nearly all biofluids compared to tissues. Each biofluid transcriptome is enriched for RNA molecules derived from specific tissues and cell types. In addition, a subset of biofluids, including stool, sweat, saliva and sputum, contains high levels of bacterial RNAs. Our atlas enables a more informed selection of the most relevant biofluid to monitor particular diseases. To verify the biomarker potential in these biofluids, four validation cohorts representing a broad spectrum of diseases were profiled, revealing numerous differential RNAs between case and control subjects. Taken together, our results reveal novel insights in the RNA content of human biofluids and may serve as a valuable resource for future biomarker studies. All spike-normalized data is publicly available in the R2 web portal and serve as a basis to further explore the RNA content in biofluids.
- 5 November 2019
- Published by Cold Spring Harbor Laboratory in bioRxiv
- p. 823369
Open AccessCharting extracellular transcriptomes in The Human Biofluid RNA Atlas
Extracellular RNAs present in biofluids have emerged as potential biomarkers for disease. Where most studies focus on plasma or serum, other biofluids may contain more informative RNA molecules, depending on the type of disease. Here, we present an unprecedented atlas of messenger, circular and small RNA transcriptomes of a comprehensive collection of 20 different human biofluids. By means of synthetic spike-in controls, we compared RNA content across biofluids, revealing a more than 10 000-fold difference in RNA concentration. The circular RNA fraction is increased in nearly all biofluids compared to tissues. Each biofluid transcriptome is enriched for RNA molecules derived from specific tissues and cell types. In addition, a subset of biofluids, including stool, sweat, saliva and sputum, contains high levels of bacterial RNAs. Our atlas enables a more informed selection of the most relevant biofluid to monitor particular diseases. To verify the biomarker potential in these biofluids, four validation cohorts representing a broad spectrum of diseases were profiled, revealing numerous differential RNAs between case and control subjects. Taken together, our results reveal novel insights in the RNA content of human biofluids and may serve as a valuable resource for future biomarker studies. All spike-normalized data is publicly available in the R2 web portal and serve as a basis to further explore the RNA content in biofluids.